C-reactive protein to identify early risk for development of calcific aortic stenosis: right marker? Wrong time?
作者信息
Stone Peter H
出版信息
J Am Coll Cardiol. 2007 Nov 13;50(20):1999-2001. doi: 10.1016/j.jacc.2007.07.065. Epub 2007 Oct 29.
PMID:17996567
Abstract
摘要
相似文献
1
C-reactive protein to identify early risk for development of calcific aortic stenosis: right marker? Wrong time?
J Am Coll Cardiol. 2007 Nov 13;50(20):1999-2001. doi: 10.1016/j.jacc.2007.07.065. Epub 2007 Oct 29.
2
Clinical factors, but not C-reactive protein, predict progression of calcific aortic-valve disease: the Cardiovascular Health Study.
J Am Coll Cardiol. 2007 Nov 13;50(20):1992-8. doi: 10.1016/j.jacc.2007.07.064. Epub 2007 Oct 29.
3
Correlation of high sensitivity C-reactive protein and calcific aortic valve disease.
Mayo Clin Proc. 2007 Feb;82(2):171-4. doi: 10.4065/82.2.171.
4
[Factors facilitating development of degenerative aortic valvular stenosis].
Klin Med (Mosk). 2005;83(6):51-4.
5
Serum gamma-glutamyltransferase activity is increased in patients with calcific aortic valve stenosis.
J Heart Valve Dis. 2008 Jul;17(4):371-5.
6
C-reactive protein in degenerative aortic valve stenosis.
Cardiovasc Ultrasound. 2006 Jun 14;4:24. doi: 10.1186/1476-7120-4-24.
7
Plasma homocysteine and calcific aortic valve disease.
Heart. 2004 Jul;90(7):802-3. doi: 10.1136/hrt.2003.022889.
8
[Aortic valve stenosis: persistence of infective agents or noninfective inflammatory process?].
Antibiot Khimioter. 2004;49(11):28-30.
9
Relationship between serum adiponectin levels and calcific aortic valve disease.
Kardiol Pol. 2013;71(3):241-6. doi: 10.5603/KP.2013.0035.
10
Spectrum of calcific aortic valve disease: pathogenesis, disease progression, and treatment strategies.
Circulation. 2005 Jun 21;111(24):3316-26. doi: 10.1161/CIRCULATIONAHA.104.486738.
Zotero 插件